Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Shares of Novavax Inc. NVAX slid 2.86% to $12.56 Wednesday, on what proved to be an all-around dismal trading session for the ...

Shares of Novavax Inc. NVAX slid 2.05% to $12.93 Tuesday, on what proved to be an all-around mixed trading session for the ...

Hello, and welcome to the UiPath Second Quarter 2025 Earnings Conference Call and Webcast. At this time all participants are in listen-only mode. [Operator Instructions] A question-and-answer ...

1, the parent strain of the most common currently circulating variants. The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 ...

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected ...

It may seem like a similar story for investors but Novavax has obtained approval for a COVID-19 vaccine -- yet again. On Aug. 30, the healthcare company announced that the Food and Drug ...

2 variant that was circulating earlier this year. FDA approved the 2023-2024 Novavax COVID-19 vaccine about a week later for individuals ages 12 and older. The updated vaccines are available at ...

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and said the vaccine is ready to ship. Novavax received the green light from ...

Begin your TipRanks Premium journey today. Novavax (NVAX) Company Description: Novavax, Inc. is a late-stage biotechnology company, which focuses on the discovery, development and ...

Novavax’s updated vaccine includes a monovalent component against the Omicron variant JN.1 strain of SARS-CoV-2. The company’s CEO John C Jacobs said: “Our updated vaccine targets JN.1, the ‘parent ...

SILVER SPRING, Md., Aug. 30, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that ...